{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/48418"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/48418","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Post-translational regulation of IDO-1 by uremic toxins","abstract":"Indolamine, 2, 3 dioxygenase (IDO-1) is a key rate limiting enzyme in the synthesis of kynurenine from tryptophan. IDO-1 is expressed mostly in endothelium, vascular smooth muscle cells and other organ systems. Previous work has shown IDO-1 is an important regulator of thrombosis in chronic kidney disease. Indoxyl sulfate, a uremic solute retained in patients of CKD, upregulates IDO-1 expression. We hypothesized that indoxyl sulfate (IS) suppresses IDO-1 ubiquitination and degradation. Here we show that IS, at the levels found in CKD patients, upregulates IDO-1. IS increases the half-life of IDO-1, suggesting an increase in stability. Screening of putative E3 ligases showed that F-box/WD Repeat-Containing Protein 4 (FBXW4), a Skp, Cullen, F-box containing complex (SCF) E3 ligase, interacts with IDO-1, downregulates IDO-1 protein expression, and shortens the half-life of IDO-1. This effect is mitigated in the presence of IS. This data suggests that FBXW4 is a candidate E3 ligase for IDO-1 and that IS may mediate its regulation on IDO-1 through FBXW4. This body of work for the first time shows a novel E3 ligase for IDO-1, especially in the context of the uremic milieu.","abstract_html":"Indolamine, 2, 3 dioxygenase (IDO-1) is a key rate limiting enzyme in the synthesis of kynurenine from tryptophan. IDO-1 is expressed mostly in endothelium, vascular smooth muscle cells and other organ systems. Previous work has shown IDO-1 is an important regulator of thrombosis in chronic kidney disease. Indoxyl sulfate, a uremic solute retained in patients of CKD, upregulates IDO-1 expression. We hypothesized that indoxyl sulfate (IS) suppresses IDO-1 ubiquitination and degradation. Here we show that IS, at the levels found in CKD patients, upregulates IDO-1. IS increases the half-life of IDO-1, suggesting an increase in stability. Screening of putative E3 ligases showed that F-box/WD Repeat-Containing Protein 4 (FBXW4), a Skp, Cullen, F-box containing complex (SCF) E3 ligase, interacts with IDO-1, downregulates IDO-1 protein expression, and shortens the half-life of IDO-1. This effect is mitigated in the presence of IS. This data suggests that FBXW4 is a candidate E3 ligase for IDO-1 and that IS may mediate its regulation on IDO-1 through FBXW4. This body of work for the first time shows a novel E3 ligase for IDO-1, especially in the context of the uremic milieu.","abstract_has_math":false,"creators":["Wu Wong, David Jasen"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Chitalia, Vipul"],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-19T02:41:58Z","subjects":["Medicine"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/48418","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/48418","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F48418","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Chitalia, Vipul"]},{"key":"dc:creator","label":"Author","values":["Wu Wong, David Jasen"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-03-18T16:40:54Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2028-03-31T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2023"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2024-03-15T19:03:43Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/48418"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Indolamine, 2, 3 dioxygenase (IDO-1) is a key rate limiting enzyme in the synthesis of kynurenine from tryptophan. IDO-1 is expressed mostly in endothelium, vascular smooth muscle cells and other organ systems. Previous work has shown IDO-1 is an important regulator of thrombosis in chronic kidney disease. Indoxyl sulfate, a uremic solute retained in patients of CKD, upregulates IDO-1 expression. We hypothesized that indoxyl sulfate (IS) suppresses IDO-1 ubiquitination and degradation. Here we show that IS, at the levels found in CKD patients, upregulates IDO-1. IS increases the half-life of IDO-1, suggesting an increase in stability. Screening of putative E3 ligases showed that F-box/WD Repeat-Containing Protein 4 (FBXW4), a Skp, Cullen, F-box containing complex (SCF) E3 ligase, interacts with IDO-1, downregulates IDO-1 protein expression, and shortens the half-life of IDO-1. This effect is mitigated in the presence of IS. This data suggests that FBXW4 is a candidate E3 ligase for IDO-1 and that IS may mediate its regulation on IDO-1 through FBXW4. This body of work for the first time shows a novel E3 ligase for IDO-1, especially in the context of the uremic milieu."]},{"key":"dc:title","label":"Title","values":["Post-translational regulation of IDO-1 by uremic toxins"]}]}],"canonical_facts":{"dc:contributor.advisor":["Chitalia, Vipul"],"dc:creator":["Wu Wong, David Jasen"],"dc:date.accessioned":["2024-03-18T16:40:54Z"],"dc:date.embargo":["2028-03-31T00:00:00Z"],"dc:date.issued":["2023"],"dc:date.updated":["2024-03-15T19:03:43Z"],"dc:description.abstract":["Indolamine, 2, 3 dioxygenase (IDO-1) is a key rate limiting enzyme in the synthesis of kynurenine from tryptophan. IDO-1 is expressed mostly in endothelium, vascular smooth muscle cells and other organ systems. Previous work has shown IDO-1 is an important regulator of thrombosis in chronic kidney disease. Indoxyl sulfate, a uremic solute retained in patients of CKD, upregulates IDO-1 expression. We hypothesized that indoxyl sulfate (IS) suppresses IDO-1 ubiquitination and degradation. Here we show that IS, at the levels found in CKD patients, upregulates IDO-1. IS increases the half-life of IDO-1, suggesting an increase in stability. Screening of putative E3 ligases showed that F-box/WD Repeat-Containing Protein 4 (FBXW4), a Skp, Cullen, F-box containing complex (SCF) E3 ligase, interacts with IDO-1, downregulates IDO-1 protein expression, and shortens the half-life of IDO-1. This effect is mitigated in the presence of IS. This data suggests that FBXW4 is a candidate E3 ligase for IDO-1 and that IS may mediate its regulation on IDO-1 through FBXW4. This body of work for the first time shows a novel E3 ligase for IDO-1, especially in the context of the uremic milieu."],"dc:identifier.uri":["https://hdl.handle.net/2144/48418"],"dc:language.iso":["en_US"],"dc:subject":["Medicine"],"dc:title":["Post-translational regulation of IDO-1 by uremic toxins"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:58Z"}